MA39550B1 - Système d'expression génique - Google Patents

Système d'expression génique

Info

Publication number
MA39550B1
MA39550B1 MA39550A MA39550A MA39550B1 MA 39550 B1 MA39550 B1 MA 39550B1 MA 39550 A MA39550 A MA 39550A MA 39550 A MA39550 A MA 39550A MA 39550 B1 MA39550 B1 MA 39550B1
Authority
MA
Morocco
Prior art keywords
gene expression
insect
expression system
lethal
conditional gene
Prior art date
Application number
MA39550A
Other languages
English (en)
Inventor
Martha Koukidou
Luke Alphey
Simon Warner
Original Assignee
Oxitec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxitec Ltd filed Critical Oxitec Ltd
Publication of MA39550B1 publication Critical patent/MA39550B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • A01K67/0337—Genetically modified Arthropods
    • A01K67/0339—Genetically modified insects, e.g. Drosophila melanogaster, medfly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/203—Animal model comprising inducible/conditional expression system, e.g. hormones, tet
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/30—Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/70—Invertebrates
    • A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/007—Vectors comprising a special translation-regulating system cell or tissue specific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/75—Vectors comprising a special translation-regulating system from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2999/00—Further aspects of viruses or vectors not covered by groups C12N2710/00 - C12N2796/00 or C12N2800/00
    • C12N2999/007—Technological advancements, e.g. new system for producing known virus, cre-lox system for production of transgenic animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne deux ou plus de deux systèmes d'expression génique conditionnels dominants létaux qui permettent d'obtenir de hauts niveaux de pénétration chez des insectes. La létalité est induite à un stade précoce de développement et le risque de résistance biochimique est réduit par comparaison avec un système unique d'expression génique conditionnel dominant létal d'insecte. L'invention est utile pour la lutte contre des populations d'insectes.
MA39550A 2014-06-05 2015-06-04 Système d'expression génique MA39550B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1410023.4A GB2526867A (en) 2014-06-05 2014-06-05 Gene expression system
PCT/GB2015/051633 WO2015185933A1 (fr) 2014-06-05 2015-06-04 Système d'expression génique

Publications (1)

Publication Number Publication Date
MA39550B1 true MA39550B1 (fr) 2018-11-30

Family

ID=51214800

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39550A MA39550B1 (fr) 2014-06-05 2015-06-04 Système d'expression génique

Country Status (18)

Country Link
US (3) US20170188559A1 (fr)
EP (1) EP3152311B1 (fr)
KR (1) KR20170012551A (fr)
CN (1) CN107075529A (fr)
AP (1) AP2016009600A0 (fr)
AR (1) AR100766A1 (fr)
AU (1) AU2015270238B2 (fr)
BR (1) BR112016028197B1 (fr)
CA (1) CA2950851A1 (fr)
CL (1) CL2016003140A1 (fr)
CR (1) CR20160594A (fr)
GB (1) GB2526867A (fr)
IL (1) IL249254B (fr)
MA (1) MA39550B1 (fr)
MX (1) MX2016016029A (fr)
PH (1) PH12016502381A1 (fr)
RU (1) RU2016151395A (fr)
WO (1) WO2015185933A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
GB2540786A (en) * 2015-07-28 2017-02-01 Glaxosmithkline Ip Dev Ltd Codon optimised tet repressor proteins
US11827876B2 (en) 2016-08-12 2023-11-28 Oxitec Ltd. Self-limiting, sex-specific gene and methods of using
CN108728477B (zh) * 2017-04-24 2022-02-22 华东理工大学 一种高效的转座突变系统及构建方法
US11968963B2 (en) 2018-04-05 2024-04-30 Vanderbilt University Male arthropod killing factors and methods of use thereof
MA52650A1 (fr) 2018-08-14 2021-12-31 Oxitec Ltd Arthropodes mâles stériles à sélection automatique

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180873A (en) 1985-04-16 1993-01-19 Dna Plant Technology Corporation Transformation of plants to introduce closely linked markers
GB8901677D0 (en) 1989-01-26 1989-03-15 Ici Plc Hybrid seed production
US5643776A (en) 1988-11-01 1997-07-01 The Regents Of The University Of California Insect diagnostic and control compositions
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5254801A (en) 1990-12-03 1993-10-19 Monsanto Company Heterologous dominant conditional lethal gene which is a phosphonate monoester hydrolase and use thereof in plants
GB9216151D0 (en) 1992-07-29 1992-09-09 Ici Plc Containment of plant germplasm
US6225121B1 (en) 1992-09-14 2001-05-01 Institute Of Molecular Biology And Biotechnology/Forth Eukaryotic transposable element
GB9313975D0 (en) 1993-07-06 1993-08-18 Sandoz Ltd Improvements in or relating to organic compounds
EG23907A (en) 1994-08-01 2007-12-30 Delta & Pine Land Co Control of plant gene expression
US5633447A (en) 1994-08-25 1997-05-27 Mycogen Plant Science, Inc. Plant tissue comprising a subgenomic promoter
US5753434A (en) 1995-02-10 1998-05-19 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for altering sexual behavior
US5851796A (en) 1995-06-07 1998-12-22 Yale University Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
FR2737731B1 (fr) 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
AUPN816196A0 (en) 1996-02-19 1996-03-14 Forbio Research Pty Ltd Regulation of eukaryotic gene expression
US5773697A (en) 1996-04-23 1998-06-30 Pioneer Hi-Bred International, Inc. Genetic constructs and methods for producing fruits with very little or diminished seed
EP0920521A1 (fr) 1996-08-26 1999-06-09 Genencor International, Inc. IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS)
AU722221B2 (en) 1996-10-01 2000-07-27 American Cyanamid Company Biological insect control agents expressing insect-specific mite toxin genes, methods and compositions
US7135608B1 (en) 1997-08-28 2006-11-14 The Salk Institute For Biological Studies Site-specific recombination in eukaryotes and constructs useful therefor
US6338040B1 (en) 1999-02-12 2002-01-08 Agren, Inc. Method for delaying the development in pest species of resistance to control techniques, using insurance to encourage correct uses of refuges
EP2395094A3 (fr) 1999-06-01 2012-04-18 The University of Utah Research Foundation Procédé de mutagénèse par transposon dans le nématode caenorhabditis elegans
GB2355459B (en) 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
JP2003521941A (ja) 2000-02-11 2003-07-22 クイーンメリー アンド ウエストフィールド カレッジ ベクター
US20030150007A1 (en) 2000-03-21 2003-08-07 Charalambos Savakis Method of generating transgenic organisms using transposons
AU2001265187A1 (en) 2000-05-30 2001-12-11 Baylor College Of Medicine Chimeric viral vectors for gene therapy
US6962810B2 (en) 2000-10-31 2005-11-08 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
EP1339863A2 (fr) 2000-12-05 2003-09-03 Wisconsin Alumni Research Foundation Procedes de transposition double destines a la manipulation d'acides nucleiques
ITRM20010120A1 (it) 2001-03-08 2002-09-08 Univ Napoli Federico Ii Gene cctra come strumento per produrre progenie di soli maschi nella mosca mediterranea ceratitis capitata.
FR2825579B1 (fr) 2001-06-11 2004-07-23 Rhobio Methode d'obtention de plante monocotyledone contenant un gene d'interet sans sequence auxiliaire etrangere
DE10251918A1 (de) 2002-11-08 2004-05-19 Horn, Carsten, Dipl.-Biochem. Dr. Systeme zur Erzeugung stabiler genomischer Transgen-Insertionen
GB2402675B (en) 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
ATE406450T1 (de) 2003-06-10 2008-09-15 Ca Nat Research Council Ein coumermycin/novobiocin-reguliertes genexpressionsystem
GB2403475B (en) 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) 2003-07-28 2008-01-30 Oxitec Ltd Pest control
CA2559280A1 (fr) 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methodes et constructions permettant d'exprimer des multimeres polypeptidiques dans des cellules eucaryotes au moyen de l'epissage alternatif
US7563601B1 (en) 2005-06-01 2009-07-21 City Of Hope Artificial riboswitch for controlling pre-mRNA splicing
MX2008010285A (es) 2006-02-10 2009-01-16 Oxitec Ltd Sistema de expresion genetica usando un empalme alternativo en insectos.
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
JP2008067678A (ja) 2006-09-15 2008-03-27 Kyushu Institute Of Technology 昆虫の減数分裂期における染色体標的組換え誘導方法
CN101688246B (zh) 2007-04-26 2013-09-25 默沙东公司 用于昆虫细胞的合成的表达载体
EP2183277A1 (fr) 2007-07-30 2010-05-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peptides sexuels resistant a une degradation proteolytique et leur utilisation dans la lutte biologique contre les insectes
WO2009115569A1 (fr) 2008-03-20 2009-09-24 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Système de létalité spécifique au stade de développement pour la régulation d’une population d’insectes
KR102261586B1 (ko) * 2008-06-27 2021-06-08 메뤼스 엔.페. 항체 생산 비-인간 포유동물
WO2011082310A2 (fr) 2009-12-30 2011-07-07 Pioneer Hi-Bred International, Inc. Procédés et compositions pour la modification ciblée de polynucléotides
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
CN104046648A (zh) * 2013-03-15 2014-09-17 中国人民解放军军事医学科学院生物工程研究所 大肠杆菌-链霉菌穿梭型bac载体及其构建方法
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
US11827876B2 (en) 2016-08-12 2023-11-28 Oxitec Ltd. Self-limiting, sex-specific gene and methods of using
AR117409A1 (es) 2018-03-29 2021-08-04 Oxitec Ltd Noctuidas autolimitantes
MA52650A1 (fr) 2018-08-14 2021-12-31 Oxitec Ltd Arthropodes mâles stériles à sélection automatique

Also Published As

Publication number Publication date
GB2526867A (en) 2015-12-09
US20240016132A1 (en) 2024-01-18
KR20170012551A (ko) 2017-02-02
US20170188559A1 (en) 2017-07-06
AU2015270238A1 (en) 2016-12-15
BR112016028197B1 (pt) 2023-09-26
PH12016502381A1 (en) 2017-02-20
MX2016016029A (es) 2017-07-11
IL249254A0 (en) 2017-02-28
EP3152311A1 (fr) 2017-04-12
WO2015185933A1 (fr) 2015-12-10
IL249254B (en) 2021-04-29
AU2015270238B2 (en) 2021-12-09
US20210137083A1 (en) 2021-05-13
CR20160594A (es) 2017-02-21
AR100766A1 (es) 2016-11-02
RU2016151395A (ru) 2018-07-17
US11737436B2 (en) 2023-08-29
CA2950851A1 (fr) 2015-12-10
EP3152311B1 (fr) 2019-08-28
AP2016009600A0 (en) 2016-12-31
GB201410023D0 (en) 2014-07-16
BR112016028197A2 (pt) 2018-07-03
CL2016003140A1 (es) 2017-10-20
CN107075529A (zh) 2017-08-18

Similar Documents

Publication Publication Date Title
MA39550B1 (fr) Système d'expression génique
BR112018069225A2 (pt) sistema de endereçamento de alvo
EP3903214A4 (fr) Défense contre l'analyse de canaux auxiliaires spéculative d'un système informatique
MA43335A (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
CL2018002874A1 (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso (divisional de solicitud n° 2413-2016).
EA201891338A1 (ru) Композиции и способы для иммуноонкологии
BR112017013448A2 (pt) composições líquidas de herbicidas contendo sulfonilureia
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
MA44927B1 (fr) Tuyau d'irrigation
EA201990333A1 (ru) Соединения, композиции и способы лечения или предотвращения симптома, ассоциированного с подагрой или гиперурикемией
CL2021002238A1 (es) Inhibidores de la vía de respuesta integrada al estrés.
CL2018001275A1 (es) Sistema de detección electroquímica de moléculas de interés
CL2016000021A1 (es) Combinación herbicida que comprende ácido pelargónico e inhibidores específicos de als
CR20190387A (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos
BR112016025627A2 (pt) biomarcadores e combinações dos mesmos para diagnóstico de tuberculose
CL2021000426A1 (es) Inhibidores de la interacción proteína-proteína keap1-nrf2.
EA202190822A1 (ru) Технологии для выполнения действий на основе обнаружения объектов
BR112018006362A2 (pt) fluido de poço com base em óleo de baixo teor de sólidos com emulsão estabilizada por partículas.
WO2015184249A3 (fr) Marqueurs de risque associé au lupus érythémateux aigu disséminé et à une maladie liée au lupus érythémateux aigu disséminé, et leurs utilisations
FR3041511B1 (fr) Dispositif de conditionnement d'une emulsion
MA55010A (fr) Système d'électrodes
FR3017703B1 (fr) Procede et systeme de determination de la compatibilite d'un guidage angulaire avec une approche
CL2017001898A1 (es) Sistema de defensa
FR3084812B1 (fr) Repulsif sanglier
BR112018001116A2 (pt) inibidor de fosfodiesterase 4 (pde4) para o tratamento de nefropatia diabética